Remark Holdings Inc buy krebskrebs
Start price
19.04.21
/
50%
€15.26
Target price
19.04.22
€22.00
Performance (%)
-60.68%
End price
20.04.22
€6.00
Summary
This prediction ended on 20.04.22 with a price of €6.00. The BUY prediction by krebskrebs for Remark Holdings Inc performed very badly with a performance of -60.68%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Remark Holdings Inc | - | - | - | - |
iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by krebskrebs for this prediction
In the thread Remark Holdings Inc diskutieren
Buy mit Kursziel 2,2
In the thread Trading Remark Holdings Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten